Successful use of oral valacyclovir in post-transplant cytomegalovirus infection in renal allograft recipients.
作者信息
Himmelmann-Jud B, Wüthrich R P, Weinreich T, Binswanger U
出版信息
Nephrol Dial Transplant. 1998 May;13(5):1326-7. doi: 10.1093/ndt/13.5.1326.
PMID:9623588
Abstract
摘要
相似文献
1
Successful use of oral valacyclovir in post-transplant cytomegalovirus infection in renal allograft recipients.
Nephrol Dial Transplant. 1998 May;13(5):1326-7. doi: 10.1093/ndt/13.5.1326.
2
The renal safety of high doses of valacyclovir for prevention of cytomegalovirus infection after renal transplantation.高剂量伐昔洛韦预防肾移植后巨细胞病毒感染的肾脏安全性
Nephrol Dial Transplant. 2000 Mar;15(3):442. doi: 10.1093/ndt/15.3.442.
3
Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis.对于接受伐昔洛韦预防治疗的肾移植受者，降低免疫抑制对治疗巨细胞病毒感染模式改变是安全有效的。
Transplant Proc. 2002 Nov;34(7):2826-7. doi: 10.1016/s0041-1345(02)03531-5.
4
Prophylaxis of cytomegalovirus infection in renal transplantation.肾移植中巨细胞病毒感染的预防
Nephrol Dial Transplant. 2001 Nov;16(11):2276-9. doi: 10.1093/ndt/16.11.2276.
5
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.伐昔洛韦预防肾移植后巨细胞病毒病。国际伐昔洛韦预防巨细胞病毒移植研究组。
N Engl J Med. 1999 May 13;340(19):1462-70. doi: 10.1056/NEJM199905133401903.
6
Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem.肾移植中巨细胞病毒感染的预防：老问题的新数据
Nephrol Dial Transplant. 1999 Oct;14(10):2304-8. doi: 10.1093/ndt/14.10.2304.
7
A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.口服更昔洛韦与口服伐昔洛韦预防肾移植后巨细胞病毒病的随机前瞻性对照试验。
Transpl Int. 2002 Dec;15(12):615-22. doi: 10.1007/s00147-002-0475-0. Epub 2002 Nov 5.
8
The economic value of valacyclovir prophylaxis in transplantation.伐昔洛韦预防在移植中的经济价值。
J Infect Dis. 2002 Oct 15;186 Suppl 1:S116-22. doi: 10.1086/342961.
9
Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial.伐昔洛韦预防心脏移植后巨细胞病毒再激活：一项随机试验。
J Heart Lung Transplant. 2002 Apr;21(4):460-6. doi: 10.1016/s1053-2498(01)00399-0.
10
Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience.低剂量伐昔洛韦在高危肾移植受者中的临床疗效：10 年经验。
Nephrol Dial Transplant. 2013 Mar;28(3):758-65. doi: 10.1093/ndt/gfs531. Epub 2012 Dec 14.
Zotero 插件